MedTrace Logo

Effects of Flavor Modification for Management of Radiation Induced Dysgeusia

NCT06311877 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-04-18

No results posted yet for this study

Summary

Intervention for dysgeusia in head and neck cancer patients undergoing radiation therapy. This research proposal aims to investigate potential benefits of mBerry in improving quality of life and nutritional outcome in head and neck cancer patients' post-radiation therapy. Our hypothesis is that cancer patients undergoing radiation therapy will benefit from use of miracle berry in treatment of dysgeusia.

Conditions

  • Dysgeusia

Interventions

DIETARY_SUPPLEMENT

mBerry

mBerry tablets (.4 grams), which contain protein within the miracle berry called miraculin.

OTHER

No intervention

The control group will not received intervention.

Sponsors & Collaborators

  • University of South Florida

    lead OTHER

Principal Investigators

  • Jennifer Larsson · University of South Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-08
Primary Completion
2026-12-14
Completion
2027-04-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06311877 on ClinicalTrials.gov